Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons
about
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsPotential therapeutic effects of neurotrophins for acute and chronic neurological diseasesSphingosine 1-phosphate signaling pathway in inner ear biology. New therapeutic strategies for hearing loss?Fingolimod for the treatment of neurological diseases-state of play and future perspectivesThe Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisPreclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-MitoxyFingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal NeuronsFingolimod (FTY720) stimulates Ca(2+)/calcineurin signaling in fission yeast.Granulocyte-colony stimulating factor attenuates oligomeric amyloid β neurotoxicity by activation of neprilysin.Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes.Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple SclerosisInterleukin-19 acts as a negative autocrine regulator of activated microgliaFingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis.Neurotrophin strategies for neuroprotection: are they sufficient?Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisBrain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.Progressive MS: from pathophysiology to drug discovery.Demyelination induced by oxidative stress is regulated by sphingosine 1-phosphate receptors.Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets.Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.FTY720 attenuates excitotoxicity and neuroinflammation.Antidepressant activity of fingolimod in mice.Activation of S1P₁ receptor regulates PI3K/Akt/FoxO3a pathway in response to oxidative stress in PC12 cells.Collagen-glycosaminoglycan matrix implantation promotes angiogenesis following surgical brain trauma.Effects of fingolimod administration in a genetic model of cognitive deficits.Testing Aβ toxicity on primary CNS cultures using drug-screening microfluidic chips.Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds
P2860
Q26765300-76727B27-8D74-4551-B859-7B0B5C8AEE07Q26827281-1705A223-2584-4E39-856B-9FA95B5EE740Q27024207-EAC6B01C-2E60-45C3-8EFE-11D28E253105Q27026175-69B45FAE-3E3E-4DF2-922E-A81A06E9A055Q28073377-0411D8F6-6522-47BD-A122-3B4D644AD26CQ28553993-636582B4-45FD-4E3E-BF14-A160F5C98DE1Q30836800-C603CF1D-0761-4A3A-AA12-1C8B210858A6Q35061388-7BB8920F-B7C1-42E6-81E7-BE1605992D98Q35213148-50DE038F-5C4E-4043-9AAE-51B1FE104049Q35330589-A467D96C-DCF7-4715-8E65-94E8EEE7A930Q35542637-CBBA037F-4F33-4108-A89F-363AE7B9FF40Q35582741-7968F4CC-E57B-4017-B925-F6D169D5376DQ36841539-3CB8CBA5-61EA-40F2-9A71-DA9C9F856B36Q37277536-2D48969F-B088-439B-A0C5-3A869A12EF7BQ37532200-0D3E0E5A-4B82-4065-AC6B-ED9B13A1667DQ38194485-255F22A5-8F3B-426C-BCF3-6DF5C5787CB0Q38216015-7F370A54-E3C5-4C15-89B8-A67DD0632E19Q38263685-373B5599-4F03-441A-A93E-589DA51BAE25Q38538932-B45A61E7-ADA4-4845-B8D9-5F3FDB4E5B0BQ38585418-E652DCAD-08A1-4870-A701-EEBEC2833A50Q38856184-6D5C68D6-3947-4BF5-B1C9-19C8AACED010Q38875349-B5B8F1C0-21C2-4820-B36D-FC36F6AA3232Q40039541-4DF1F67F-F67F-4F87-9F15-1E28E0BDB7E3Q40613316-ED6028BC-0464-49BA-8388-2FE675302680Q41359968-55666EEE-26AA-48F8-9677-5AE92056D9BBQ41656417-F6F655CC-2773-448C-BF43-280F8DCA6071Q42107295-8C58E91C-0278-45FD-ABA1-C80B05F0FFADQ48613672-B159F011-CAC1-4F3D-90DC-B89562867841Q48722845-D8905E54-5148-4984-9320-07F512DA7EE8Q58691421-95E2960F-1E5B-40B2-9F66-387D52B545A7
P2860
Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Fingolimod phosphate attenuate ...... c factor expression in neurons
@ast
Fingolimod phosphate attenuate ...... c factor expression in neurons
@en
Fingolimod phosphate attenuate ...... c factor expression in neurons
@nl
type
label
Fingolimod phosphate attenuate ...... c factor expression in neurons
@ast
Fingolimod phosphate attenuate ...... c factor expression in neurons
@en
Fingolimod phosphate attenuate ...... c factor expression in neurons
@nl
prefLabel
Fingolimod phosphate attenuate ...... c factor expression in neurons
@ast
Fingolimod phosphate attenuate ...... c factor expression in neurons
@en
Fingolimod phosphate attenuate ...... c factor expression in neurons
@nl
P2093
P2860
P921
P3181
P1433
P1476
Fingolimod phosphate attenuate ...... c factor expression in neurons
@en
P2093
Akio Suzumura
Bijay Parajuli
Hideyuki Takeuchi
Jun Kawanokuchi
Shijie Jin
Taketo Hanyu
Tetsuya Mizuno
Yoshifumi Sonobe
Yukiko Doi
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0061988
P407
P577
2013-04-12T00:00:00Z